Adriana C. H. van Engen–van Grunsven

Author

Also Known As

A. C. H. van Engen-van Grunsven, A.C.H. van Engen-van Grunsven, Adriana C H Van Engen-Van Grunsven, Adriana C H van Engen-van Grunsven, Adriana C. H. Van Engen–Van Grunsven, Adriana C. H. van Engen-Van Grunsven, Adriana C. H. van Engen-van Grunsven, Adriana C. H. van Engen‐van Grunsven, Adriana C. H. van Engen–van Grunsven, Adriana C.H. van Engen-van Grunsven

Publications

982

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Leiden University Medical Center Humanitas University University of Twente

About

Adriana C. H. van Engen–van Grunsven is an author at Radboud University Nijmegen specializing in medicine, pathology, and surgical pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	316
2	Health Sciences	1	1	36
3	Cell Biology	1	1	17
4	Molecular Genetics	1	1	17
5	Obstetrics	1	1	72

Adriana C. H. van Engen–van Grunsven

Publications

634

Citations

H-Index

Page 1

	Year	Citations
HRAS-mutated Spitz Tumors Adriana C. H. van Engen–van Grunsven, Marcory C. R. F. van Dijk, Dirk J. Ruiter, The American Journal of Surgical Pathology Hras MutationSpitz NevusTumoral PathologyTumor HeterogeneityMedicine	2010	113
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma Wim van Boxtel, Laura D. Locati, Adriana C. H. van Engen–van Grunsven, European Journal of Cancer Endocrine OncologyMedicineGynecologyBreast CancerSalivary Gland	2019	72
NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract—A study of 24 cases from the Netherlands Adriana C. H. van Engen–van Grunsven, Heidi V.N. Küsters‐Vandevelde, Joanne A. de Hullu, Gynecologic Oncology UrologyGenitourinary CancerSurgical PathologyKit MutationsMelanoma	2014	47
SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas Heidi V.N. Küsters‐Vandevelde, David Creytens, Adriana C. H. van Engen–van Grunsven, Acta Neuropathologica Communications	2016	45
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial Elizabeth J. de Koster, Lioe‐Fee de Geus‐Oei, Adrienne H. Brouwers, European Journal of Nuclear Medicine and Molecular Imaging	2022	42
Autophagy activity is associated with membranous sodium iodide symporter expression and clinical response to radioiodine therapy in non-medullary thyroid cancer Theo S. Plantinga, Marika H. Tesselaar, Hans Morreau, Autophagy Cell AutophagyEndocrine-related CancerNon-medullary Thyroid CancerMedicineThyroid Disease	2016	36
Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer Henrieke W. Schutte, Guido B. van den Broek, Stefan C. A. Steens, Cancer	2020	36
Accuracy of parotid gland FNA cytology and reliability of the Milan System for Reporting Salivary Gland Cytopathology in clinical practice Sam T. H. Reerds, Adriana C. H. van Engen–van Grunsven, Frank J. A. van den Hoogen, Cancer Cytopathology	2021	36
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma Maike J.M. Uijen, Gerben Lassche, Adriana C. H. van Engen–van Grunsven, Oral Oncology	2022	24
Assessment of surgical tumor‐free resection margins in fresh squamous‐cell carcinoma resection specimens of the tongue using a clinical MRI system Jan Heidkamp, Willem L. J. Weijs, Adriana C. H. van Engen–van Grunsven, Head & Neck	2020	23

Page 1